Bernard Calandra

4.9k total citations · 2 hit papers
15 papers, 4.1k citations indexed

About

Bernard Calandra is a scholar working on Pharmacology, Cellular and Molecular Neuroscience and Surgery. According to data from OpenAlex, Bernard Calandra has authored 15 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pharmacology, 10 papers in Cellular and Molecular Neuroscience and 5 papers in Surgery. Recurrent topics in Bernard Calandra's work include Cannabis and Cannabinoid Research (14 papers), Neurotransmitter Receptor Influence on Behavior (7 papers) and Pancreatic function and diabetes (5 papers). Bernard Calandra is often cited by papers focused on Cannabis and Cannabinoid Research (14 papers), Neurotransmitter Receptor Influence on Behavior (7 papers) and Pancreatic function and diabetes (5 papers). Bernard Calandra collaborates with scholars based in France and United Kingdom. Bernard Calandra's co-authors include Gérard Le Fur, David Shire, Murielle Rinaldi‐Carmona, Francis Barth, Pierre Casellas, Pascual Ferrara, Monsif Bouaboula, Daniel Caput, Christian Congy and M Rinaldi-Carmona and has published in prestigious journals such as Journal of Biological Chemistry, Biochemical Journal and FEBS Letters.

In The Last Decade

Bernard Calandra

15 papers receiving 4.0k citations

Hit Papers

SR141716A, a potent and selective antagonist of the brain... 1994 2026 2004 2015 1994 1998 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. SR141716A, a potent and selective antagonist of the brain cannabinoid receptor
    1994 1.5k citations Murielle Rinaldi‐Carmona, Francis Barth et al. FEBS Letters profile →
  2. SR 144528, the First Potent and Selective Antagonist of the CB2 Cannabinoid Receptor
    1998 593 citations M Rinaldi-Carmona, Francis Barth et al. Journal of Pharmacology and Experimental Therapeutics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bernard Calandra France 15 3.8k 2.5k 761 692 604 15 4.1k
Murielle Rinaldi‐Carmona France 20 3.5k 0.9× 2.4k 1.0× 731 1.0× 588 0.8× 578 1.0× 26 3.9k
Francis Barth France 21 3.3k 0.9× 2.3k 0.9× 652 0.9× 630 0.9× 574 1.0× 33 3.8k
Michael Bayewitch Israel 18 2.9k 0.8× 1.9k 0.8× 663 0.9× 982 1.4× 409 0.7× 21 3.8k
Lisa A. Matsuda United States 12 4.8k 1.3× 3.1k 1.2× 1.0k 1.4× 671 1.0× 682 1.1× 17 5.3k
Shinji Nakane Japan 18 3.2k 0.9× 1.6k 0.6× 683 0.9× 666 1.0× 468 0.8× 21 3.8k
Raphael Mechoulam Israel 13 3.5k 0.9× 1.8k 0.7× 761 1.0× 314 0.5× 471 0.8× 16 3.8k
Christian Congy France 10 2.4k 0.6× 1.7k 0.7× 526 0.7× 406 0.6× 465 0.8× 10 2.8k
Alex Straiker United States 33 2.7k 0.7× 1.9k 0.7× 828 1.1× 789 1.1× 385 0.6× 81 3.7k
C. S. Breivogel United States 22 2.5k 0.7× 2.0k 0.8× 549 0.7× 498 0.7× 353 0.6× 36 3.0k
Darren Fegley United States 9 2.4k 0.7× 1.5k 0.6× 603 0.8× 281 0.4× 269 0.4× 10 2.8k

Countries citing papers authored by Bernard Calandra

Since Specialization
Citations

This map shows the geographic impact of Bernard Calandra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernard Calandra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernard Calandra more than expected).

Fields of papers citing papers by Bernard Calandra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernard Calandra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernard Calandra. The network helps show where Bernard Calandra may publish in the future.

Co-authorship network of co-authors of Bernard Calandra

This figure shows the co-authorship network connecting the top 25 collaborators of Bernard Calandra. A scholar is included among the top collaborators of Bernard Calandra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernard Calandra. Bernard Calandra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Gouldson, Paul R., Bernard Calandra, Pascale Legoux, et al.. (2000). Mutational analysis and molecular modelling of the antagonist SR 144528 binding site on the human cannabinoid CB2 receptor. European Journal of Pharmacology. 401(1). 17–25. 51 indexed citations
2.
Shire, David, Bernard Calandra, Monsif Bouaboula, et al.. (1999). Cannabinoid receptor interactions with the antagonists SR 141716A and SR 144528. Life Sciences. 65(6-7). 627–635. 80 indexed citations
3.
Calandra, Bernard, Marielle Portier, Christine Carillon, et al.. (1999). Dual intracellular signaling pathways mediated by the human cannabinoid CB1 receptor. European Journal of Pharmacology. 374(3). 445–455. 85 indexed citations
4.
Portier, M, M Rinaldi-Carmona, Florence Pecceu, et al.. (1999). SR 144528, an Antagonist for the Peripheral Cannabinoid Receptor that Behaves as an Inverse Agonist. Journal of Pharmacology and Experimental Therapeutics. 288(2). 582–589. 89 indexed citations
5.
Rinaldi-Carmona, M, Francis Barth, Jean‐Marie Derocq, et al.. (1998). SR 144528, the First Potent and Selective Antagonist of the CB2 Cannabinoid Receptor. Journal of Pharmacology and Experimental Therapeutics. 284(2). 644–650. 593 indexed citations breakdown →
6.
Bouaboula, Monsif, Laura Milligan, Xavier Canat, et al.. (1997). A Selective Inverse Agonist for Central Cannabinoid Receptor Inhibits Mitogen-activated Protein Kinase Activation Stimulated by Insulin or Insulin-like Growth Factor 1. Journal of Biological Chemistry. 272(35). 22330–22339. 396 indexed citations
7.
Calandra, Bernard, Julie A. Tucker, David Shire, & Reinhard Grisshammer. (1997). Expression in Escherichia coli and characterisation of the human central CB1 and peripheral CB2 cannabinoid receptors. Biotechnology Letters. 19(5). 425–428. 26 indexed citations
8.
Shire, David, Bernard Calandra, Murielle Rinaldi‐Carmona, et al.. (1996). Molecular cloning, expression and function of the murine CB2 peripheral cannabinoid receptor. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1307(2). 132–136. 163 indexed citations
9.
Shire, David, Bernard Calandra, Xavier Dumont, et al.. (1996). Structural Features of the Central Cannabinoid CB1 Receptor Involved in the Binding of the Specific CB1 Antagonist SR 141716A. Journal of Biological Chemistry. 271(12). 6941–6946. 87 indexed citations
10.
Bouaboula, Monsif, Caroline Poinot‐Chazel, Jean Marchand, et al.. (1996). Signaling Pathway Associated with Stimulation of CB2 Peripheral Cannabinoid Receptor. European Journal of Biochemistry. 237(3). 704–711. 244 indexed citations
11.
Rinaldi-Carmona, M, Bernard Calandra, David Shire, et al.. (1996). Characterization of two cloned human CB1 cannabinoid receptor isoforms.. Journal of Pharmacology and Experimental Therapeutics. 278(2). 871–878. 104 indexed citations
12.
Shire, David, Christine Carillon, Mourad Kaghad, et al.. (1996). An amino-terminal variant of the central cannabinoid receptor resulting from alternative splicing. Journal of Biological Chemistry. 271(52). 33706–33706. 14 indexed citations
13.
Shire, David, Christine Carillon, Mourad Kaghad, et al.. (1995). An Amino-terminal Variant of the Central Cannabinoid Receptor Resulting from Alternative Splicing. Journal of Biological Chemistry. 270(8). 3726–3731. 264 indexed citations
14.
Bouaboula, Monsif, Caroline Poinot‐Chazel, B. Bourrié, et al.. (1995). Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1. Biochemical Journal. 312(2). 637–641. 444 indexed citations
15.
Rinaldi‐Carmona, Murielle, Francis Barth, Michel Héaulme, et al.. (1994). SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Letters. 350(2-3). 240–244. 1489 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Murielle Rinaldi‐Carmona Breakdown of academic impact, for papers by Francis Barth Breakdown of academic impact, for papers by Michael Bayewitch Breakdown of academic impact, for papers by Lisa A. Matsuda Breakdown of academic impact, for papers by Shinji Nakane Breakdown of academic impact, for papers by Raphael Mechoulam Breakdown of academic impact, for papers by Christian Congy Breakdown of academic impact, for papers by Alex Straiker Breakdown of academic impact, for papers by C. S. Breivogel Breakdown of academic impact, for papers by Darren Fegley
Rankless by CCL
2026